Understanding Leukapheresis

What is Leukapheresis?

Leukapheresis might sound like a complex medical term, but at its core, it’s a life-saving procedure that plays a crucial role in modern healthcare. Simply put, leukapheresis is a process used to separate white blood cells (leukocytes) from a patient’s blood. These cells are then either removed or used for therapeutic or research purposes. Imagine it like filtering out specific ingredients from a soup—you keep what you need and remove what you don’t. That’s essentially what leukapheresis does with blood.

This procedure is widely used in treating conditions such as leukemia, autoimmune diseases, and other blood-related disorders. But that’s not all—it has also become a cornerstone in advanced medical innovations like cell and gene therapy, where high-quality white blood cells are required as raw material. The growing importance of such therapies is one of the major reasons why the leukapheresis market is gaining attention globally.

What makes leukapheresis particularly fascinating is its dual role. On one hand, it’s used therapeutically to reduce harmful white blood cells in patients. On the other, it’s a key enabler for cutting-edge research, especially in immunotherapy and regenerative medicine. As healthcare continues to evolve, leukapheresis is no longer just a procedure—it’s becoming a critical bridge between traditional medicine and futuristic treatments.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148

How Leukapheresis Works

Now, you might be wondering—how exactly does this process work? The answer lies in advanced medical devices known as apheresis machines. During leukapheresis, blood is drawn from the patient and passed through a machine that separates its components using centrifugal force or filtration techniques. The desired white blood cells are collected, while the remaining components, like red blood cells and plasma, are returned to the patient’s body.

This closed-loop system ensures minimal blood loss and maintains patient stability throughout the procedure. It’s safe, efficient, and typically performed in specialized healthcare settings like hospitals or blood centers. The entire process can take a few hours, depending on the purpose and volume of cells required.

What’s truly remarkable is how technology has enhanced this process over the years. Modern leukapheresis systems are increasingly automated, reducing human error and improving efficiency. These advancements are not just improving patient outcomes but also driving the growth of the global leukapheresis market.

Market Overview and Key Statistics

Market Size in 2025 and 2026

The global leukapheresis market has shown steady growth in recent years, reflecting its increasing importance in modern medicine. According to recent data, the market was valued at USD 83.3 million in 2025 and grew to USD 90.6 million in 2026. 

This growth might seem modest at first glance, but it represents a significant expansion in a highly specialized segment of the healthcare industry. The increasing demand for advanced therapies, coupled with the rising incidence of blood disorders, has been a key driver behind this upward trend.

Another interesting aspect is the growing adoption of leukapheresis in research settings. Universities, biotech firms, and pharmaceutical companies are increasingly relying on this technology to develop new treatments. This shift is gradually transforming leukapheresis from a niche medical procedure into a critical component of the global healthcare ecosystem.

Forecast to 2031 and CAGR Analysis

Looking ahead, the future of the leukapheresis market appears promising. The market is projected to reach USD 138.7 million by 2031, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2031. 

To put this into perspective, an 8.9% CAGR indicates strong and consistent growth over the forecast period. This is not just a temporary spike—it’s a sustained upward trajectory driven by multiple factors, including technological advancements and increasing healthcare investments.

Here’s a quick snapshot:

This steady growth highlights the increasing reliance on leukapheresis in both clinical and research applications. As new therapies continue to emerge, the demand for high-quality leukocyte collection is expected to rise, further fueling market expansion.

Speak To Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20283148

Key Growth Drivers

Rising Prevalence of Blood Disorders

One of the biggest factors driving the leukapheresis market is the increasing incidence of blood-related diseases, particularly leukemia and lymphoma. As these conditions become more prevalent, the need for effective treatment options grows. Leukapheresis plays a vital role in managing these diseases by removing excess white blood cells from the bloodstream.

In many cases, leukapheresis is used as an emergency intervention to quickly reduce dangerously high white blood cell counts. This not only improves patient outcomes but also creates a consistent demand for leukapheresis procedures worldwide.

Expansion of Cell and Gene Therapy

If there’s one trend reshaping the healthcare industry, it’s the rise of cell and gene therapy (CGT). These therapies rely heavily on high-quality immune cells, which are often collected using leukapheresis. 

Think of leukapheresis as the “raw material supplier” for these advanced treatments. Without it, therapies like CAR-T cell therapy wouldn’t be possible. As more CGT products receive regulatory approval and enter the market, the demand for leukapheresis is expected to skyrocket.

Increasing Clinical Trials

Another major growth driver is the surge in clinical trials focused on immunotherapy and regenerative medicine. Pharmaceutical companies and research institutions are investing heavily in these areas, leading to increased demand for leukapheresis procedures.

Clinical trials require consistent and high-quality cell samples, and leukapheresis provides exactly that. This growing research activity is not only boosting market demand but also encouraging innovation in leukapheresis technologies.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=20283148

Market Segmentation Analysis

By Product Type

Devices

Leukapheresis devices are the backbone of the procedure. These machines are responsible for separating blood components and collecting white blood cells. Advances in device technology, such as automation and improved efficiency, are driving their adoption in healthcare settings.

Disposables

Disposables, including tubing sets and collection kits, dominate the market. In fact, this segment accounted for 79.8% of the market share in 2025.  This dominance is due to the recurring need for single-use components, which ensures safety and reduces the risk of contamination.

By Application

Research Applications

Research applications are expected to grow at the fastest rate, with a projected CAGR of around 9.0%.  This growth is driven by the increasing focus on developing new therapies and understanding disease mechanisms.

Therapeutic Applications

Therapeutic applications remain a significant segment, particularly in the treatment of blood disorders. Leukapheresis is often used as a frontline treatment in certain medical conditions, ensuring steady demand in this segment.

Technological Advancements in Leukapheresis

Automated Systems

Technology is transforming leukapheresis in ways we couldn’t have imagined a decade ago. Modern systems are becoming increasingly automated, reducing the need for manual intervention and improving efficiency.

GMP-Compliant Technologies

Good Manufacturing Practice (GMP)-compliant systems are gaining traction, especially in cell therapy applications. These systems ensure that collected cells meet strict quality standards, making them suitable for advanced medical treatments.

Regional Insights

North America Market Trends

North America continues to dominate the leukapheresis market, thanks to its advanced healthcare infrastructure and strong presence of key market players.

Asia-Pacific Growth Potential

Asia-Pacific is expected to grow at the fastest rate, with a projected CAGR of around 10.0%.  This growth is driven by increasing healthcare investments and rising awareness about advanced treatments.

Europe Market Landscape

Europe remains a significant market, supported by strong research activities and favorable regulatory frameworks.

Competitive Landscape

Key Market Players

Some of the leading companies in the leukapheresis market include:

• Fresenius Kabi

• Terumo BCT

• Haemonetics Corporation

• Grifols S.A.

• Miltenyi Biotec 

These companies are focusing on innovation and strategic partnerships to strengthen their market position.

Strategic Developments

From mergers and acquisitions to product launches, the competitive landscape is dynamic. Companies are investing heavily in R&D to stay ahead in this rapidly evolving market.

Challenges in the Leukapheresis Market

High Procedure Costs

Despite its benefits, leukapheresis is an expensive procedure. The high cost can limit its accessibility, especially in developing regions.

Limited Skilled Professionals

Performing leukapheresis requires specialized training. The shortage of skilled professionals can hinder market growth.

Opportunities and Future Outlook

Emerging Markets

Emerging economies present significant growth opportunities, thanks to improving healthcare infrastructure and increasing investments.

Personalized Medicine Growth

The shift toward personalized medicine is expected to drive demand for leukapheresis, as it enables customized treatments based on individual patient needs.

Conclusion

The global leukapheresis market is on a steady growth path, driven by advancements in medical technology and increasing demand for innovative therapies. With a projected value of USD 138.7 million by 2031 and a strong CAGR of 8.9%, the market offers significant opportunities for stakeholders across the healthcare ecosystem. 

FAQs

1. What is leukapheresis used for?

Leukapheresis is used to separate and collect white blood cells for therapeutic treatments and research purposes.

2. Why is the leukapheresis market growing?

The market is growing due to rising blood disorders, increasing cell therapy demand, and technological advancements.

3. What is the projected market size by 2031?

The market is expected to reach USD 138.7 million by 2031.

4. Which region is growing the fastest?

Asia-Pacific is projected to grow at the highest CAGR.

5. What are the key challenges in this market?

High costs and lack of skilled professionals are major challenges.